Blinatumomab in induction therapy improves molecular response
in untreated adults with Ph- B-cell precursor acute
lymphoblastic leukemia

ENPřihlásit se Přihlásit se (EduID)

Blinatumomab in induction therapy improves molecular response in untreated adults with Ph- B-cell ...

Přehled o publikaci

J 2025

Blinatumomab in induction therapy improves molecular response in untreated adults with Ph- B-cell precursor acute lymphoblastic leukemia

SALEK, Cyril; Štěpán HRABOVSKÝ; František FOLBER; Zdenek KORISTEK; Jan M HORACEK et. al.

Základní údaje

Originální název

Blinatumomab in induction therapy improves molecular response in untreated adults with Ph- B-cell precursor acute lymphoblastic leukemia

Autoři

Vydání

haematologica, PAVIA, FERRATA STORTI FOUNDATION, 2025, 0390-6078

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Stát vydavatele

Itálie

Utajení

není předmětem státního či obchodního tajemství

Odkazy

URL

Organizace

Lékařská fakulta – Masarykova univerzita – Repozitář

DOI

https://doi.org/10.3324/haematol.2024.287062

UT WoS

001524687800023

EID Scopus

2-s2.0-105009547616

Klíčová slova anglicky

Blinatumomab; acute lymphoblastic leukemia; Ph- B-cell precursor

Návaznosti

LX22NPO5102, projekt VaV. NU22-03-00210, projekt VaV. CZECRIN IV, velká výzkumná infrastruktura.

Změněno: 15. 10. 2025 00:51, RNDr. Daniel Jakubík

Anotace

V originále

lt;10-. Patients treated in their first complete remission (CR) showed better outcomes than those treated in later remissions. These findings support integrating blinatumomab into first-line polychemotherapy, as early MRD clearance significantly improves survival and reduces risk of relapse.

Přiložené soubory

https://is.muni.cz/publication/2511397/Blinatumomab_in_induction_therapy_improves_molecular_response_in_untreated_adults_with_Ph-_B-cell_precursor_acute_lymphoblastic_leukemia.pdf

Citovat

SALEK, Cyril; Štěpán HRABOVSKÝ; František FOLBER; Zdenek KORISTEK; Jan M HORACEK; Eva FRONKOVA; Leona Rezkova REZNICKOVA; Pavla PECHERKOVA; Petr SOUKUP; Barbora DLUHOSOVA; Vaclava POLIVKOVA; Jitka KRIZKOVA; Katerina MACHOVA POLAKOVA; Zuzana VRZALOVÁ; Hana HALÁMOVA; Jan TRKA; Petr CETKOVSKY a Michael DOUBEK. Blinatumomab in induction therapy improves molecular response in untreated adults with Ph- B-cell precursor acute lymphoblastic leukemia. haematologica. PAVIA: FERRATA STORTI FOUNDATION, 2025, roč. 110, č. 7, s. 1644-1648. ISSN 0390-6078. Dostupné z: https://doi.org/10.3324/haematol.2024.287062.

@article{80287,
   author = {Salek, Cyril and Hrabovský, Štěpán and Folber, František and Koristek, Zdenek and Horacek, Jan M and Fronkova, Eva and Reznickova, Leona Rezkova and Pecherkova, Pavla and Soukup, Petr and Dluhosova, Barbora and Polivkova, Vaclava and Krizkova, Jitka and Machova Polakova, Katerina and Vrzalová, Zuzana and Halámova, Hana and Trka, Jan and Cetkovsky, Petr and Doubek, Michael},
   article_location = {PAVIA},
   article_number = {7},
   doi = {https://doi.org/10.3324/haematol.2024.287062},
   keywords = {Blinatumomab; acute lymphoblastic leukemia; Ph- B-cell precursor},
   language = {eng},
   issn = {0390-6078},
   journal = {haematologica},
   title = {Blinatumomab in induction therapy improves molecular response in untreated adults with Ph- B-cell precursor acute lymphoblastic leukemia},
   url = {https://haematologica.org/article/view/11946},
   volume = {110},
   year = {2025}
}

TY  - JOUR
ID  - 80287
AU  - Salek, Cyril - Hrabovský, Štěpán - Folber, František - Koristek, Zdenek - Horacek, Jan M - Fronkova, Eva - Reznickova, Leona Rezkova - Pecherkova, Pavla - Soukup, Petr - Dluhosova, Barbora - Polivkova, Vaclava - Krizkova, Jitka - Machova Polakova, Katerina - Vrzalová, Zuzana - Halámova, Hana - Trka, Jan - Cetkovsky, Petr - Doubek, Michael
PY  - 2025
TI  - Blinatumomab in induction therapy improves molecular response in untreated adults with Ph- B-cell precursor acute lymphoblastic leukemia
JF  - haematologica
VL  - 110
IS  - 7
SP  - 1644-1648
EP  - 1644-1648
PB  - FERRATA STORTI FOUNDATION
SN  - 0390-6078
KW  - Blinatumomab
KW  - acute lymphoblastic leukemia
KW  - Ph- B-cell precursor
UR  - https://haematologica.org/article/view/11946
N2  - lt;10-. Patients treated in their first complete remission (CR) showed better outcomes than those treated in later remissions. These findings support integrating blinatumomab into first-line polychemotherapy, as early MRD clearance significantly improves survival and reduces risk of relapse.
ER  -

SALEK, Cyril; Štěpán HRABOVSKÝ; František FOLBER; Zdenek KORISTEK; Jan M HORACEK; Eva FRONKOVA; Leona Rezkova REZNICKOVA; Pavla PECHERKOVA; Petr SOUKUP; Barbora DLUHOSOVA; Vaclava POLIVKOVA; Jitka KRIZKOVA; Katerina MACHOVA POLAKOVA; Zuzana VRZALOVÁ; Hana HALÁMOVA; Jan TRKA; Petr CETKOVSKY a Michael DOUBEK. Blinatumomab in induction therapy improves molecular response in untreated adults with Ph- B-cell precursor acute lymphoblastic leukemia. \textit{haematologica}. PAVIA: FERRATA STORTI FOUNDATION, 2025, roč.~110, č.~7, s.~1644-1648. ISSN~0390-6078. Dostupné z: https://doi.org/10.3324/haematol.2024.287062.